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Abstract 
Advanced bioactive systems with defined macroscopic properties and spatio-temporal 
sequestration of extracellular biomacromolecules are highly desirable for next generation therapeutics. 
Here, chitosan hydrogels were prepared with neutral or negatively-charged crosslinkers in order to 
promote selective electrostatic complexation with charged drugs. Chitosan (CT) was functionalised 
with varied dicarboxylic acids, such as tartaric acid (TA), poly(ethylene glycol) bis(carboxymethyl) 
ether (PEG), 1.4-Phenylenediacetic acid (4Ph) and 5-Sulfoisophthalic acid monosodium salt (PhS), 
whereby PhS was hypothesised to act as a simple mimetic of heparin. ATR FT-IR showed the 
presence of C=O amide I, N-H amide II and C=O ester bands, providing evidence of covalent network 
formation. The crosslinker content was reversely quantified by 
1
H-NMR on partially-degraded 
network oligomers, so that 18 mol.-% PhS was exemplarily determined. Swellability (SR: 299±65–
1054±121 wt.-%), compressability (E: 2.1±0.9–9.2±2.3 kPa), material morphology, and drug-loading 
capability were successfully adjusted based on the selected network architecture. Here, hydrogel 
incubation with model drugs of varied electrostatic charge, i.e. allura red (AR, --), methyl orange (MO, 
-) or methylene blue (MB, +), resulted in direct hydrogel-dye electrostatic complexation. Importantly, 
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the cationic compound, MB, showed different incorporation behaviours, depending on the 
electrostatic character of the selected crosslinker. In light of this tuneable drug-loading capability, 
these CT hydrogels would be highly attractive as drug reservoirs towards e.g. the fabrication of tissue 
models in vitro. 
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Graphical abstract 
Systematic chitosan functionalisation resulted in 
hydrogels with varied network architecture, electrostatic 
charge and macroscopic properties, so that bespoke 
hydrogel loading was successfully accomplished by 
controlling the electrostatic dye-hydrogel complexation.  
 
1. Introduction 
In in vivo tissue engineering, multifunctional material systems should temporally mimic natural 
tissues, exhibiting controlled macroscopic properties and inducing specific biological signals to local 
stem cells [1].
 
In vivo, these functions are provided by the extracellular matrix (ECM), a highly 
organised supramolecular hydrogel structure binding and stabilising growth factors in a spatio-
temporal, controlled manner [2]. ECM sulfated glycosaminoglycans, such as heparin, protect bound 
growth factors from proteolytic degradation, potentiating their bioactivity by facilitating cell receptor 
interactions [3]. Consequently, the design of advanced bioactive systems mimicking ECM growth 
factor features in a defined, application-dependent, temporal fashion, is currently considered one of 
the greatest challenges in regenerative medicine [4, 5].  
Functional biomaterials, including hydrogels [5, 6, 7, 8, 9, 10, 11], sponges [12], scaffolds [13], 
electrospun meshes [14] and capsules [15], have been extensively investigated for the localised 
loading and controlled release of growth factors. Among the different carrier systems, hydrogels are 
attractive material candidates since they are generally biocompatible, biodegradable and can mimic 
ECM architecture over different length scales [16, 17]. At the same time, their high swelling and hard 
to control elasticity and degradability must be carefully addressed in order to ensure a timely and 
sustained material performance without compromising loading and release profiles [9]. Using 
functionalised dextran hydrogels, Schillemans et al. applied reversible electrostatic interactions for 
post-loading and release of proteins [18]. Here, protein incorporation was not homogeneous and 
nearly-complete release was observed following 50 hours. Aiming at sustained and localised delivery, 
Jeon et al. synthesised growth factor-encapsulating hydrogels [19]. Here, covalently-linked heparin 
segments were expected to mimic ECM growth factor-binding sites, although release was found to be 
mainly driven by diffusion rather than network degradation. In an effort to control loading and release 
capability independently of network characteristics, Freudenberg et al. described a modular system of 
biohybrid hydrogels based on covalently cross-linked heparin and star-shaped poly(ethylene glycols) 
[5]. Although mechanical properties and biofunctionality could be ruled independently, up to only 
about 5 wt.-% loading was observed
†
, while nearly 20 wt.-% of loaded growth factor was released 
within 7 days. Besides biopolymer-based hydrogels, surface-modified synthetic hydrogel networks 
have also been established, whereby pH-triggered, hour-scale, release of model drugs was 
demonstrated [11]. From all the aforementioned examples, it appears rather clear that successful 
clinical translation of current hydrogel systems as controlled drug delivery systems has been deterred 
by setbacks such as (i) poor loading efficiency, (ii) large initial burst release and (iii) limited control 
in material properties. An interesting approach to address these challenges is based on the design of 
functional hydrogel reservoirs allowing for the controlled loading of a wide range of biomolecules, 
whereby stimulus-triggered drug release can be obtained. To reach this goal, the molecular network 
architecture must be thoroughly investigated, so that defined structure-property-function relationships 
can be established [20]. 
Chitosan (CT) is the second most abundant natural polymer on earth and serves as a structural 
polysaccharide for many phyla of lower plants and animals. CT is derived from the partial 
deacetylation of chitin, thereby resulting in the only linear cationic polysaccharide. It contains 
glucosamine and N-acetylglucosamine units along its polymer backbone, so that it mimics the 
chemical composition of ECM glycosaminoglycans. In light of its suitable biodegradability, 
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biocompatibility, immunological, antibacterial and wound-healing properties as well as good 
mechanical and film-forming properties [ 21 , 22], CT has therefore been widely applied in the 
biomedical field as a wound dressing [23], haemostat [24] and scaffold for tissue engineering [25, 26], 
and as controlled drug [27] and gene [28] delivery vehicles. At the same time, CT’s polycationic 
nature should be carefully considered for the successful formulation of bespoke drug delivery 
systems, due to the potential electrostatic repulsion of the polymer backbone with positively-charged 
growth factors, such as BMP-2 or FGF-2 [ 29 ]. Furthermore, a non-controllable electrostatic 
complexation of the material surface with cells may be observed following protonation of CT amino 
groups in vitro or in vivo, ultimately leading to cytotoxic effects. To circumvent these issues, chemical 
functionalisation of CT can be carried out, whereby reaction of amino and hydroxyl terminations 
leads to the establishment of covalent, neutralised, net-points, so that the polycationic character of CT 
is controlled [30, 31, 32]. CT has been carboxymethylated [33, 34], grafted with phenylalanine [35] 
and crosslinked with low-molecular weight segments [36], leading to a broad range of polymers. 
However, despite such enormous polymer variability, the fact that CT solubility is restricted to acidic 
conditions imposes several constraints in terms of accomplishing selective and tuenable 
functionalisation, so that systematic changes in molecular organisation are highly challenging. Indeed, 
reacted products might be unstable at acidic pH, potentially resulting in occurrence of side reactions 
and reduced reaction yield, so that material properties and drug loading/release functionalities cannot 
be systematically varied. 
This work aimed at establishing a novel synthetic approach for the formation of bioactive 
CT-based systems displaying tunable network architecture and superior drug-loading functionality. It 
was hypothesised that selective CT functionalisation could be accomplished in aqueous systems with 
bifunctional segments of varied molecular weight, backbone rigidity, wettability and electrostatic 
charge, so that bespoke hydrogels with defined macroscopic properties could be formed. Based on the 
selected network architecture, it was hypothesised that hydrogel drug-loading functionality could 
result from the electrostatic complexation of the network chains with systematically-varied model 
drugs. To reach this goal, L(+)-tartaric acid (TA), poly(ethylene glycol) bis(carboxymethyl) ether 
(PEG), 4-Phenylenediacetic acid (4Ph), and 5-Sulfoisophthalic acid monosodium salt (PhS) were 
selected as dicarboxylic acids for CT functionalisation. TA and PEG have been previously applied to 
CT for the design of pH-responsive nanoparticles [32] and drug delivery hydrogels [36]. Here, both 
compounds were employed as flexible, aliphatic, neutral crosslinkers of varied molecular weight. 4Ph 
and PhS were selected as rigid, aromatic segments, whereby the only difference between the two 
molecules was the presence of a sulfonic acid group in PhS benzene ring, aimed at mimicking the 
growth factor-binding sites of heparin in vivo. Consequently, incubation in solutions containing either 
allura red (AR) as doubly negatively-charged, methyl orange (MO) as negatively-charged and 
methylene blue (MB) as positively-charged, model drugs was carried out in order to explore hydrogel 
loading functionality [37]. Thus, CT systems with systematically adjusted material properties and 
loading efficiencies via selective changes in network architecture were expected to be established. 
Ongoing research is focusing on the evaluation of the controlled drug release functionality in the 
presented chitosan systems.  
 
2. Materials and methods 
2.1. Materials 
Low molecular weight (50000-190000 Da) CT, N-(3-Dimethylaminopropyl)-N-
ethylcarbodiimide hydrochloride (EDC), N-hydroxysuccinimide (NHS), PEG (average Mn ~  600 Da) 
and hydrochloric acid solution (37%) were purchased from Sigma Aldrich (Japan). 1-
Hydroxybenzotriazole (HOBt) was purchased from Kishida Chemical Co., Ltd. (Japan). PhS, 4Ph and 
TA were purchased from Tokyo Chemical Industry Co., Ltd. (Japan). Allura red, methylene blue and 
methylene orange were purchased from Tokyo Chemical Industry Co. Ltd. (Japan), Kishida Chemical 
Co., Ltd. (Japan) and Nacalai Tesque, Inc. (Japan), respectively. Deuterium oxide was purchased from 
Wako Pure Chemical Industries, Ltd. (Japan). 
 
2.2. Formation of CT -based hydrogels 
CT -based hydrogels were prepared by dissolving CT (0.15 g) in a HOBt (0.12 g)-water (4.23 g) 
solution [38]. Once the CT solution was obtained, an equimolar content of dicarboxylic acid (either 
TA, PEG, 4Ph or PhS) with respect to the CT amino functions was activated in water (0 °C, pH 4, 30 
min.) with EDC (1 or 2.3 M) in the presence of NHS. A three-fold excess of EDC/NHS with respect 
to the dicarboxylic acid molar content was introduced. NHS-activated dicarboxylic acid mixture was 
mixed with previously-obtained CT solution and incubated at room temperature under gentle shaking, 
in order to allow for the nucleophilic addition reaction of CT amino groups to the crosslinker 
carboxylic functions to occur. Complete gel formation was observed following 1-hour reaction of CT 
with selected NHS-activated dicarboxylic acids. Resulting hydrogels were thoroughly washed with 
distilled water, followed by vacuum-drying at room temperature.  
 
2.3. Chemical characterisation of hydrogel networks 
Attenuated Total Reflectance Fourier-Transform Infrared (ATR FT-IR) was carried out on dry 
samples using a Perkin-Elmer Spectrum 100 FT-IR spectrophotometer with diamond ATR 
attachment. Scans were conducted from 4000 to 400 cm
-1
 with 16 repetitions averaged for each 
spectrum at 4 cm
−1
 resolution. In order to investigate the molar content of introduced crosslinkers, 5 
mg hydrogel CT-PhS was exemplarily incubated in 5 M HCl solution at 60 °C until complete network 
degradation. Partially-degraded oligomers were dried at 40 °C with reduced pressure. 
1
H-NMR 
spectra were recorded at room temperature on a JEOL GSX 400 spectrophotometer (400 MHz) by 
dissolving 10 mg of dry oligomers in 1 mL deuterium oxide. Signals at δ= 8.4 ppm and δ=8.5 were 
selected to identify PhS species, while the signal at δ=4.4 ppm was chosen to describe CT backbone. 
Consequently, the sulfonic acid content incorporated in the hydrogel was quantified according to the 
following equation: 
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 whereby S(mol.-%) identifies hydrogel sulfonic acid molar content, while 
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1
H-NMR integrations related to PhS- and CT -based signals, respectively. 
   
 
 
 
 
 
2.4. Swelling tests 
Swelling tests were carried out by incubating dry samples in 5 mL aqueous medium, either 
distilled water or PBS (pH 7.4), at room temperature for 24 hours. Water-equilibrated samples were 
retrieved, paper-blotted and weighed. The weight-based swelling ratio (SR) was calculated as:  
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SR          (Equation 2) 
where ms and md are swollen and dry sample weights, respectively. Three replicas were used for each 
sample composition, so that SR results were expressed as average ± standard deviation. Single factor 
ANOVA was carried out to determine the statistical significance between experimental groups. A 
value of p < 0.05 was considered to be statistically significant. 
 
2.5. Compression tests 
Water-equilibrated hydrogel discs (ø 0.8 cm) were compressed at room temperature with a 
compression rate of 3 mm·min
-1 
(EZ test, Shimadzu Corporation, Japan). A 500 N load cell was 
operated up to sample break. The maximal compressive stress (σmax) and compression at break (εb) 
were recorded, so that the compressive modulus (E) was calculated by fitting the linear region of the 
stress-strain curve. At least three replicas were employed for each composition and results expressed 
as average ± standard deviation. 
 
2.6. Thermogravimetric analysis 
Thermogravimetric analysis (TGA, TG/DTA 6200, Seiko Instruments Inc., Japan) was 
conducted on dry samples in order to investigate the thermal stability of formed networks. TGA tests 
were carried out under nitrogen atmosphere (50 mL·min
-1
 nitrogen flow rate range) with 10 °C·min
-1
 
heating rate from 10 to 500 °C.  
 
2.7. Scanning electron microscopy 
The internal architecture of formed hydrogels was investigated following freeze-drying. Freeze-
dried samples were mounted on metal stubs using double-sided carbon adhesive tape and coated with 
osmium tetroxide by HPC-30 plasma coater (Vacuum Device Inc.). Coated samples were inspected 
with JEOL JSM-6700FE field emission scanning electron microscope, whereby the pore size was 
determined by direct measurements (n= 2-8). 
 
2.8. Drug loading into CT hydrogel  
Allura red AC (AR, λmax = 504 nm), methyl orange (MO, λmax = 505 nm) and methylene blue 
(MB, λmax = 661 nm) were used as doubly negatively-, negatively- and positively-charged model 
drugs, respectively, in order to estimate hydrogel loading functionality. A stock solution of each dye 
was prepared in distilled water at a final concentration of 0.1 mg·mL
-1
. The stock solution was further 
diluted before incubation of a water-equilibrated hydrogel (10-50 mg) in 4 mL dye solution (0.025 
mg∙mL-1). At selected incubation time points, the incubating solution was collected in a cuvette and 
analyzed via a UV spectrophotometer U-3010 (Hitachi High-Technologies Corporation, Japan). Thus, 
hydrogel loading with model drugs was quantified according to the following equation: 
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whereby XX identifies the loading model drug, i.e. AR, MO or MB; Amax,d indicates the maximum 
absorbance of the model drug solution before incubation of the hydrogel sample, while Amax,t  
describes the maximum absorbance of the solution supernatant following hydrogel incubation at 
selected loading time points. 
 
3. Results and discussion 
CT hydrogels with varied crosslinkers, controlled macroscopic properties and tunable drug-
loading functionality were successfully synthesised (Scheme 1). These hydrogels were colourless and 
transparent in their gelled unloaded state; following drug loading the gels took on the colour of the 
relevant drug (Figure S1, Supporting Information shows an image of hydrogel CT-PhS following AR 
loading). CT was dissolved in HOBt aqueous solution, as an effective, reliable and cell-friendly 
system to directly functionalise CT avoiding any pre-derivatisation step or acidic conditions [38]. 
Reaction with selected NHS-activated dicarboxylic acids led to complete gel formation within 30 min 
reaction. Here, nucleophilic addition of CT amino and hydroxyl functions to activated crosslinkers 
takes place [22], leading to a covalent network consisting of hydrolytically-cleavable amide net-points 
(Scheme 1, A). Thus, either intra- or inter-molecular crosslinks can be introduced in CT chains, 
depending on the molecular rigidity, molecular weight and feed ratio of selected crosslinking 
segments (Scheme 1, B). Consequently, materials with varied macroscopic properties and internal 
geometry could be accomplished. Furthermore, hydrogel electrostatic charge was expected to be 
tuned based on resulting network architectures, so that loading with a wide range of drugs could be 
successfully obtained via electrostatic drug-hydrogel complexation (Scheme 1, C). In the following, 
CT-based hydrogels will be characterised as for their network architecture, swellability, thermo-
mechanical properties, material morphology and drug-loading functionality, aiming at establishing 
systems with defined structure-property-function relationships. Samples are coded as CT(XX%)-
YYY, whereby CT indicates a CT-based hydrogel, XX identifies the wt.-% CT concentration in the 
reacting mixture, while YYY states the type of crosslinker introduced in resulting networks, either 
TA, PEG, 4Ph or PhS.   
 
Scheme 1. Formation of CT-based hydrogels with varied network architecture and tunable drug-loading functionality. (A): 
A dicarboxylic acid segment is activated with EDC/NHS and reacted with an aqueous solution of CT-HOBt. (B): Molecular 
formula of selected bifunctional segments: Tartaric acid (1., TA), poly(ethylene glycol) bis(carboxymethyl) ether (2., PEG),  
1,4-Phenylenediacetic acid (3., 4Ph), Monosodium 5-Sulfoisophthalate (4., PhS). (C): Drug-loading functionality of 
CT-based hydrogels: native CT (–) behaves as a polycation in aqueous solution due to the protonation of amino and 
hydroxyl functions (I). By covalently functionalising CT with either negatively- or positively-charged bifunctional segments 
(–), hydrogel electrostatic charge can be promptly varied (II). Adjustment in backbone electrostatic charge is exploited to 
achieve hydrogel loading with drug model compounds (●) via electrostatic complexation (III).  
 
3.1. Chemical composition and network architecture   
Vacuum-dried CT -based networks were investigated via ATR FT-IR in order to explore the 
chemical composition in formed materials and elucidate the mechanism of network formation. 
Spectral analysis was then combined with 
1
H-NMR spectroscopy on oligomers resulting from 
network degradation in acidic conditions, in order to quantify the crosslinker content in the covalent 
networks. Figure 1 displays FT-IR spectra of native and crosslinked CT following reaction with 
selected bifunctional segments. Distinctive FT-IR bands of CT are at 3450 cm
-1
 (O–H stretch), 2872 
cm
-1
 (C–H stretch), 1646 cm-1 (Amide I), 1590 cm-1 (Amide II), 1152 cm-1 (bridge-O stretch), and 
1090 cm
-1
 (C–O stretch) [34, 36]. Each of these bands was found in all acquired spectra, confirming 
the CT-based composition in resulting samples. At the same time, increased intensities of Amide I and 
II bands, while an additional band at 1740 cm
-1
, were observed in crosslinked, in comparison to native 
CT, spectra. The former finding is likely to confirm the presence of a covalent network consisting of 
amide net-points formed following the reaction between CT amino terminations and activated 
carboxylic groups of the crosslinkers. Furthermore, the new peak at 1740 cm
-1
 is likely to identify the 
C=O band of ester groups formed following the reaction of hydroxyl functions with activated diacids.  
 
Figure 1. Exemplary ATR-FTIR spectra of CT (a), CT(2.2%)-TA (b), CT(2.2%)-PEG (c), CT(2.2%)-4Ph (d),  and 
CT(2.2%)-PhS (e). The presence of Amide I (1650 cm-1), Amide II (1550 cm-1) and Ester (1730 cm-1) bands in 
functionalised, compared to native, CT confirms the formation of a covalent network via reaction of carboxylic terminations 
of selected bifunctional segments with amino and hydroxyl functions of CT, respectively. 
 
The lower intensity of this band compared to amide bands suggests that hydroxyl group 
functionalisation is less favoured, which is expected due to the lower reactivity of hydroxyl compared 
to amino functions. Other than that, no additional band characteristic of selected diacids was observed 
in resulting sample spectra, likely due to the much lower crosslinker, compared to CT, content. 
Besides ATR FT-IR, it was of interest to quantify the crosslinker content effectively incorporated 
in formed hydrogels. This information was crucial in order to elucidate the molecular architecture of 
resulting networks and understand how this affected hydrogel macroscopic properties and drug-
loading functionality. Covalent, non-soluble, hydrogel networks are indeed challenging to characterise 
precisely, since main molecular parameters, such as network crosslinking density, can only be 
determined indirectly following equilibrium-swelling and rubbery-elasticity theories. However, noisy 
experimental conditions are usually associated with the determination of these molecular parameters, 
so that only semi-quantitative conclusions can be drawn [39]. In order to overcome these limitations, a 
reverse approach was pursued for the characterisation of network architecture, whereby selected a CT 
hydrogel was fully-degraded in acidic conditions and resulting oligomers analysed via 
1
H-NMR 
spectroscopy.  
 
Figure 2. 
1H-NMR spectra (D2O, 25 °C) of native CT (top), PhS (middle) and partially-degraded oligomers (bottom) formed 
following hydrolysis (5 M HCl, 60 °C) of hydrogel CT(2.2%)-PhS. Signals related to PhS- (Ha, Hb) and CT- (H1) based 
species were clearly identified in oligomers spectra, so that the PhS content in resulting hydrogels was successfully 
quantified (~ 18 mol.-%).  
 
Accordingly, samples of CT(2.2%)-PhS, as an exemplary hydrogel system, were selected since it was 
of particular interest to investigate how introduced sulfonic acid moieties influenced hydrogel 
swellability and drug-loading functionality (sulfonic acid being responsible for basic growth factor 
sequestration in tissue ECM).   
Figure 2 displays the 
1
H-NMR spectra of native CT, PhS and partially-degraded oligomers, 
respectively. Here, PhS- (Ha, Hb) and CT- (H1) related signals could be clearly distinguished in the 
spectrum of partially-degraded network oligomers, whereby no overlap with any other species was 
observed. This finding provides supporting evidence that network degradation only takes place via 
hydrolytic cleavage of either amide or ester bond net-points, resulting from the PhS-mediated CT 
functionalisation. Consequently, CT-related signal H1 could still be identified following network 
degradation, so that quantitative information was successfully obtained via integration ratio of PhS-
related signals (Ha, Hb) and CT reference signal (H1, Equation 1). Accordingly, a sulfonic acid content 
of 18 mol.-% was determined. As for comparison, Muzzarelli functionalised CT with 5-formyl-2-
furansulfonic acid to obtain an anticoagulant polymer analogue, whereby a sulfation degree of less 
than 4% was obtained, although an additional chloromethylation step was required [40]. Following a 
similar approach, Hoven et al. synthesised N-sulfofurfuryl-bearing CT films [41], so that the sulfation 
degree was increased up to nearly 8%; however, the reaction was carried out in the bulk state so that a 
non-homogeneous functionalisation was expected. In contrast to previous approaches, requiring 
additional reaction steps and resulting in low, non-tunable functionalisation, this synthetic route is 
highly advantageous, since it enables the direct functionalisation of CT with enhanced degree of 
functionalisation, so that functional, tunable hydrogels can be successfully obtained. Due to the 
versatility of this synthesis, it is expected that the degree of functionalisation can be increased further 
by tuning the crosslinker: CT feed molar ratio. 
 
 
3.2. Swellability of CT-based hydrogels 
The swelling ratio (SR) was quantified in either distilled water (pH 6.5) or PBS (0.1 M, pH 7.4) 
in order to investigate material behaviour in physiologically-relevant conditions. Figure 3 describes 
SR values for the different hydrogel compositions; SR of resulting chitosan networks was  varied in 
the range of 300-1100 wt.-%; networks crosslinked with PEG showed the highest SR variation (SR: 
500-1100 wt.-%), followed by samples CT-TA (300-600 wt.-%) and CT-PhS (400-600 wt.-%), whilst 
samples CT-4Ph took up the lowest amount of aqueous medium (300-400 wt.-%). Hydrogels CT-PhS 
displayed slightly higher SR in PBS compared to distilled water, although the opposite trend was 
observed in all other networks, with significant differences observed in systems CT(1.5%)-TA and 
CT(2.2%)-PEG. Moreover, changes in reacting CT concentration significantly affected the 
swellability of PEG- (following incubation in both distilled water and PBS) and TA-based (following 
incubation in PBS only) systems, despite there being only a very small change in reacting CT 
concentration (1.5-2.2 wt.-%). Overall, the following parameters were observed to rule the swelling 
behaviour of resulting CT networks: (i) network architecture, whereby variations were mainly based 
on the wettability, backbone rigidity and molecular weight of applied crosslinkers; (ii) CT 
concentration in the crosslinking mixture; (iii) electrostatic contributions resulting from the swelling 
medium, occurrence of free (i.e. amino) CT terminations and/or ionically-charged groups (i.e. sulfonic 
acid moieties) introduced following crosslinking.  
                     
Figure 3. Left: Swelling ratio (SR) of CT-based hydrogels following equilibration in either distilled water (grey) or PBS 
(light grey) at room temperature. ‘*’ and ‘a’ indicate that related mean differences are significant at 0.05 level (Bonferroni 
test). ‘b’ and ‘c’ indicate that corresponding mean values are significantly different to all mean values described in the plot 
(at 0.05 level, Bonferroni test). Right: SR of CT-based hydrogels following equilibration in PBS at room temperature. ‘*’ 
and ’**’ indicate that corresponding mean values are significantly higher compared to all other mean values described below 
the black line (at 0.05 level, Bonferroni test); ‘a’ indicates that compared mean values are significantly different between 
each other at 0.05 level (Bonferroni test); ‘b’ indicates that corresponding mean value is significantly different from all other 
mean values described in the plot (at 0.05 level, Bonferroni test).  
 
Hydrogel swelling is driven by the spontaneous mixing of network chains with water, whilst the 
presence of covalent net-points among polymer chains prevents the dissolution of the network, 
although contribution from ionic moieties also plays a major role. In order to understand the swelling 
behaviour of obtained CT systems, it is therefore crucial to focus on their molecular organisation. 
Given that the same reaction mechanism was employed for network formation (Scheme 1, A) and a 
constant molar feed ratio was applied, differences in network crosslinking density are unlikely to be 
expected among the different CT systems. Consequently, the network architecture will be mainly 
affected by the molecular structure of each crosslinking segment, described by its molecular weight, 
molecular rigidity, wettability and electrostatic charge, although  the ionic contribution deriving from 
non-reacted amino terminations of chitosan also needs to be considered. Considering the former 
aspect, the enhanced swellability observed in PEG- (in either distilled water or PBS), and in some 
cases in TA- (mainly in PBS), based systems can be mainly ascribed to the increased hydrophilicity 
and flexibility of both PEG and TA compared to employed aromatic, rigid crosslinkers, such as 4Ph 
and PhS. Likewise, the lower swellability observed in TA- compared to PEG-based systems is likely 
related to the varied crosslinker molecular weight, since this molecular parameter rules network 
elasticity and extensibility during swelling [42]. Thus, higher swelling is likely to be expected in 
networks crosslinked with longer segments compared to networks crosslinked with segments of 
decreased molecular weight. Other than crosslinker molecular weight and backbone rigidity, the 
swelling medium is also shown to play a major role in hydrogel swellability. The reason for this 
interesting  behaviour in obtained CT systems is to be found in the polycationic nature of native CT. 
CT pKa is 6.2-7 [21, 32], so that its amino terminations are protonated in distilled water (pH 6.5), 
while they are likely neutralised in PBS (0.1 M, pH 7.4). This effect is reduced in crosslinked CT and 
inversely-related to the network crosslinking density, since free amino groups will be functionalised 
to form amide bonds, as observed via ATR FT-IR (Figure 1). Consequently, in CT networks 
crosslinked with non-ionically charged segments, i.e. TA, PEG, and 4Ph, non-functionalised amino 
groups will be protonated in distilled water, so that the electrostatic repulsion between them will 
promote increased swelling. In contrast, no repulsion will be present in PBS since all free amino 
terminations will be neutralised, resulting in decreased SR. This behaviour is slightly reversed in the 
case of PhS-functionalised CT, given that additional, negatively-charged moieties are established 
along crosslinked chains. In distilled water, sulfonic acid groups will be able to mediate additional 
electrostatic crosslinks with free, protonated amino groups, so that decreased SR is observed (Figure 
3). At the same time, such electrostatic interactions will disappear in PBS, since free CT amino groups 
will be neutralised in these conditions. Consequently, SR is slightly increased due to the electrostatic 
repulsion between negatively-charged sulfonic acid moieties.  
 
3.3. Thermo-mechanical properties of CT systems 
Thermal analysis was carried out via TGA on dry networks in order to get an insight on the 
thermal material stability and network morphology, while mechanical properties were investigated via 
compression tests on water-equilibrated hydrogels. Figure 4 describes TGA thermograms of native 
and crosslinked CT samples. Thermal phenomena such as water loss, material decomposition and 
combustion were exhibited by all samples. At the same time, no additional thermal event was 
observed in crosslinked compared to native CT, indicating that no presence of by-products or 
non-reacted moieties could be observed. The synthesis of pure, fully-crosslinked covalent networks 
was therefore proved following hydrogel formation and washing. Native CT displayed a weight loss 
between 50 and 150 °C which is obviously related to the water evaporation from the sample. Such 
weight loss is also observed in the crosslinked materials although in a smaller extent, especially in the 
case of TA-based networks, probably due to the presence of covalent net-points limiting the amount 
of fluid imbibed and retained by the network. Compared to native CT, crosslinked samples displayed 
lower thermal stability (< 250 °C). These observations likely suggest that inter- rather than 
intramolecular functionalisation of polymer chains is obtained following network formation, so that 
CT crystallisation is inhibited [21, 35]. Furthermore, the material thermal stability is affected only 
slightly by the molecular rigidity of introduced aromatic or aliphatic crosslinkers.  
 Figure 4. TGA thermograms of CT networks: CT (–·–), CT(2.2%)-TA (—), CT(2.2%)-PEG (—), CT(2.2%)-4Ph (—), 
CT(2.2%)-PhS (···). 
 
Water-equilibrated hydrogels were investigated by compression tests at room temperature. Here, 
stress-strain curves were varied based on the network architecture of hydrogel samples (Figure 5), so 
that resulting compressive moduli (E) were obtained in the low kPa range (2-9 kPa). PEG- and 4Ph-
based systems showed the lowest and highest E value, respectively, while mechanical properties of 
TA- and PhS-based systems were within the two extremes. These mechanical observations are in 
agreement with aforementioned network architecture and swelling considerations, whereby samples 
showing increased SR exhibited decreased E and vice-versa. PEG is a polymeric hydrophilic, aliphatic 
segment, resulting in systems with enhanced elasticity and swellability, and reduced compressive 
modulus, in comparison to the other CT hydrogels. In contrast, 4Ph is an aromatic, bulky crosslinker, 
thereby leading to the formation of hydrogels with increased mechanical properties and decreased 
swellability. TA and PhS display intermediate molecular features between these two compounds. TA 
is a low-molecular weight aliphatic segment, so that the molecular weight between two covalent net-
points will be reduced in TA- compared to PEG-based systems. Consequently, decreased elasticity 
and swellability as well as increased compressive modulus will be expected in resulting networks. 
PhS is an aromatic crosslinker (unlike PEG molecule) containing an additional ionically-charged 
sulfonic acid moiety with respect to 4Ph compound.  
 Figure 5. Compressive stress (σ)-strain (ε) curves of chitosan-based hydrogels. From top to bottom: CT(2.2%)-4Ph (black), 
CT(2.2%)-TA (dark gray), CT(2.2%)-PEG (gray), , CT(2.2%)-PhS (light gray). Compressive moduli were calculated (n ≥ 3) 
in the linear region and were observed to be affected by the specific network architecture. 
 
The decreased compression modulus observed in CT-PhS compared to CT-4Ph samples is therefore 
likely related to the electrostatic repulsion occurring during the compression of the hydrogel network. 
Here, crosslinked chains of CT-PhS network become closer, since the material is stressed in 
compression. This molecular mechanism is likely to explain the decreased compression modulus in 
CT-PhS with respect to CT-4Ph samples, although the swelling ratio in distilled water between these 
sample formulations is similar.       
 
3.4. SEM morphological investigation 
Since obtained CT systems were intended for biomedical applications, e.g. as drug reservoirs or 
scaffold for tissue engineering, it was of interest to explore material surface morphology and inner 
geometry. In both applications, the presence of pores play an important role in hydrogel properties, 
such as swelling [21], compressability [43] and cell adhesion [44], and can enhance nutrient diffusion, 
waste exchange as well as induce local angiogenesis following material implantation in vivo [25]. 
Figure 6 displays SEM pictures of freeze-dried network surfaces and cross-sections. Samples 
exhibited a porous morphology, whereby pore size (Ø 60-400 µm) was changed based on the selected 
CT system. TA-crosslinked CT exhibited a highly porous architecture (Ø 271±100 µm) with nearly-
rounded pores observed either in the outer or inner sections, in contrast to hydrogels CT-PEG (Ø 
82±24 µm) and CT-4Ph (Ø 62±5 µm).  
 Figure 6. Scanning electron microscopy (SEM) on freeze-dried CT-based networks.  
 
At the same time, PhS-based samples revealed the presence of bigger pores (Ø 411±47 µm) in the 
inner structure, while the material surface was nearly bulky. Interestingly, the pore size of freeze-dried 
systems was that of previously-reported, gas-foamed CT-based scaffolds [25]. Given that no specific 
scaffold formation method was applied, it is likely that observed pores derived from the reaction 
conditions employed during hydrogel formation. Air-bubbles can indeed be introduced in the polymer 
solution during stirring, remaining entrapped in the hydrogel following network formation. 
Consequently, pores are expected to be formed in the resulting material following freeze-drying [45].  
Selected crosslinkers are likely to influence air-bubble stabilisation and thereby resulting material 
morphology. Slightly-hydrophobic moieties are supposed to enhance phase separation in foamed-like 
solutions [46], so that homogeneous pores of decreased size can be formed, as observed in the case of 
4Ph-based systems. In contrast, crosslinkers of increased hydrophilicity are expected to destabilise the 
air-liquid phase separation, so that coalescence and disproportionation of air-bubble is likely, 
ultimately resulting in pores of increased size and decreased occurrence. Such morphological features 
are clearly observed in samples CT-TA and, to some extent, in samples CT-PhS, but not in the case of 
samples CT-PEG. The varied molecular weight between TA and PEG is likely to count for the 
different material morphology between the two systems, since polymers of increased molecular 
weight will have an effect on the solution viscosity, which is another physical parameter crucial for air 
bubble stabilisation [46]. With the presented synthetic strategy, it was therefore possible to 
accomplish CT networks with crosslinking segments of varied wettability, so that pores with varied 
pore size could be formed adjusted towards specific clinical applications, such as osteoid ingrowth 
(Ø 40-100 µm) or bone regeneration (Ø 100-350 µm) [25]. 
  
3.5. Drug-loading functionality in CT systems 
In view of the versatility of these CT systems, it was of particular interest to investigate whether 
the formation of selected network architectures could result in advanced and tailorable drug-loading 
functionalities. By functionalisation of CT with selected crosslinkers, it was hypothesised that 
network electrostatic charge could be systematically tuned in order to promote hydrogel-drug 
electrostatic complexation with a wide range of drugs. Hydrogels CT-PEG, CT-4Ph and CT-PhS were 
incubated in aqueous solutions of either AR, MO or MB and the maximum absorbance of the 
supernatant monitored over time, in order to quantify any drug loading onto the material (Equation 3). 
Figure 7 (a) displays absorbance curves of MB solution at different time points following incubation 
with hydrogel CT-PhS. Here, the maximum absorbance peak is decreased at increased incubation time 
points, indicating a reduction of MB content in the supernatant, likely related to MB loading into the 
hydrogel. Significant decrease in absorbance was observed following 24 hours incubation, 
corresponding to the time window nedeed to enable equilibration of CT networks with distilled water.  
               
(a)               (b) 
        
(c)                (d) 
Figure 7. Typical loading behaviour of CT-based systems studied via UV-vis incubation experiments with dyes 
of varied electrostatic charge. Absorbance curve of MB-containing solution during incubation with hydrogels 
CT(2%)-PhS (a). Peak of MB absorbance at 661 nm is decreased at increased incubation time points (0, 12, 24, 
36, 48, 60, 84 h), providing evidence of MB loading in the CT hydrogel. MB (b), MO (c) and AR (d) loading 
curves in hydrogels CT(2%)-PhS (–■–), CT(2%)-4Ph (--♦--), CT(2%)-PEG (··▲··).Triplicates were applied for 
the loading of hydrogels CT(2%)-PhS with MO; minimal standard deviation was observed between replicas at 
each loading time point (Loading: 1.04 ± 0.74 – 3.89 ± 1.07), giving supporting evidence of the system 
reproducibility. Hydrogels are selectively loaded with dyes of opposite electrostatic charge, due to the 
electrostatic hydrogel-dye complexation occurring following hydrogel incubation. 
  
At the same time, the maximum absorbance peak was mostly suppressed following 84 hours hydrogel 
incubation, indicating that MB loading onto the hydrogel was almost complete. From a molecular 
point of view, MB is a positively-charged compound, similarly to growth factors such as FGF-2 or 
BMP-2. Due to its cationic character, electrostatic repulsion with CT, resulting in minimal loading 
efficiency, should be expected [27, 28]. MB was dissolved in distilled water, at which pH protonation 
of CT amino groups takes place, as demonstrated via swelling tests (Figure 3). The only reason 
explaining the high MB loading onto hydrogels CT-PhS is therefore related to the presence of sulfonic 
acid moieties covalently bonded to CT backbone: such negatively-charged groups are likely to 
mediate electrostatic complexation with MB positively-charged groups, so that localised electrostatic 
complexation can successfully occur, ultimately resulting in almost complete loading. Further to that, 
no visible colour change was observed when loaded hydrogels were incubated (for at least three days) 
in distilled water, suggesting that only minimal burst release may be expected following hydrogel 
loading.  
In order to further understand the molecular mechanism ruling hydrogel loading capability, 
hydrogel loading with selected model drugs was quantified by monitoring the variation in maximum 
absorbance. Figure 7 (b) describes MB loading plots for samples CT-PhS, CT-4Ph and CT-PEG. As 
observed from the suppressed absrobance peak (Figure 7, b), CT-PhS could load up to 88% MB 
following 84 hours incubation, while the other two samples showed less than 20 % loading. 
Compared to that, the situation is completely reversed when hydrogels are incubated with solutions 
containing negatively-charged MO (Figure 7, b), whereby samples CT-PhS displayed only mininal 
adsorption (< 5%), while increased loading was observed in hydrogels CT-4Ph (~ 40%) and CT-PEG 
(~ 65%). Different loading capabilities were again observed when hydrogels were incubated with AR 
(Figure 7, c), so that samples CT-PEG highlighted more than 90% loading, followed by samples CT-
PhS (~ 70%), while samples CT-4Ph displayed nearly 50% loading. The wide difference between the 
loading capabilities of tested hydrogels confirmed a direct relationship with the molecular architecture 
of selected hydrogel networks. Hydrogels CT-PhS were unable to load negatively-charged MO, an 
observation which is directly ascribed to the electrostatic repulsion of this compound with CT-bound 
sulfonic acid moiety. In contrast to that, significant loading was observed in the same system with 
doubly-negatively charged AR, whereby the hydrogel turned red following dye incorporation in the 
material (Figure S1, Supporting Information). This finding is likely related to the fact that electrostatic 
complexation between non-functionalised, protonated CT amino terminations is more likely in the 
case of AR compared to MO, due to the increased density of negatively-charged moeties. 
Consequently, the previously-observed drug repulsion with PhS-functionalised CT could be 
overcome. Other than that, the high AR and MO as well as low MB loadings of PhS-free CT systems 
further support aferomentioned explanations, thereby demonstrating that tunable and localised 
hydrogel-drug electrostatic complexation could be successfully established based on the systematic 
variation in network architecture. Therefore, the drug-loading capability of formed CT systems was 
successfully ruled by the polymer functionalisation with selected bifuctional crosslinkers, so that a 
wide range of varied model drugs could be applied. In light of this direct relationship between 
network architecture and drug-loading functionality, the loading efficiency was significantly enhanced 
compared to previously-reported alginate- [9], poly(glutamic acid)- [10], , and PEG- [5, 29] based 
hydrogels. 
 
Conclusions 
Functionalised CT systems were successfully prepared. Bifunctional segments varying in 
molecular weight, backbone rigidity and electrostatic charge were applied to selectively functionalise 
CT in order to investigate the changing trends in network architecture, macroscopic properties and 
drug-loading capability. Systematically-adjusted swellability, and compressability were observed by 
applying selected crosslinkers, while a varied range of model drugs were successfully loaded into the 
systems via hydrogel-drug electrostatic complexation. In order to form tunable CT systems via a 
reliable, effective and cell-friendly synthetic route, CT was functionalised in a HOBt-water mixture, 
allowing for the direct formation of TA-, PEG-, 4Ph- and PhS-based hydrogels. Precise quantification 
of the crosslinker content was reversely obtained via acidic degradation of obtained hydrogels, so that 
an enhanced degree of CT functionalisation (S~ 18 mol.-%) was determined via 
1
H-NMR on 
exemplarily-formed oligomers CT-PhS. Network thermal stability was decreased compared to native 
CT, likely due to the formation of inter- rather than intramolecular netpoints, so that polymer 
crystallinity was decreased. At the same time, internal material morphology was affected depending 
on the molecular structure of incorporated crosslinkers. Based on the selected network architecture, 
swellability (SR: 299±65–1054±121 wt.-%) and compressability (E: 2.1±0.9–9.2±2.3 kPa) could be 
promptly adjusted. Furthermore, the electrostatic charge of hydrogel networks was varied leading to 
the promotion of selective complexation with a wide range of model drugs, i.e. AR, MO and MB, so 
that hydrogel loading was successfully adjusted (1-100%). Introduction of heparin-mimicking 
sulfonic acid moieties was crucial to ensure full MB loading in CT-PhS networks. This finding was 
not accomplished in any of the other network architectures, including 4Ph-bearing networks. This 
confirms the hypothesis that the sulfonic acid group is key in promoting chitosan binding to 
positively-charged model drugs, which is not possible in native chitosan. Consequently, a direct 
method to promptly alter the polycationic feature of chitosan was successfully established, potentially 
paving the way to selective and controlled loading and release of positively-charged growth factors. 
Because these CT systems can mimic biological tissues on a mechanical, molecular and functional 
level, next steps are focusing on the application of these materials as drug reservoirs, whereby 
sustained drug release can be obtained. Since selective loading was demonstrated with model drugs, 
CT systems will be investigated with growth factors, e.g. FGF-2 and BMP-2, in order to further 
explore the biofunctionality of these hydrogels as drug carriers.  
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